Endorsement of registration identifies practitioners with additional qualifications and specific expertise. The endorsement available for podiatry is scheduled medicines.
The Podiatry Board of Australia’s revised registration standard for endorsement for scheduled medicines and associated guidelines came into effect on 1 August 2018.
The revised registration standard and guidelines apply to podiatrists and podiatric surgeons applying for endorsement for scheduled medicines after 1 August 2018.
FAQ are available to help practitioners understand the new registration standard and guidelines.
Templates and a Prescribing Self Assessment Tool are also available to support practitioners using Pathway B of the registration standard to endorsement.
Watch our two videos about Pathway B to endorsement for scheduled medicines and discover what you and your mentor need to do during your period of supervised practice.
Video: Endorsement for scheduled medicines – key steps for Pathway B
Video: Key information about the mentor role under Pathway B
There are specific forms for practitioners applying to have their registration endorsed for scheduled medicines.
There are also forms to complete if you need to change your mentor or if you want to apply for an extension of time to complete your period of supervised practice under Pathway B.
The forms are available on our Forms page.
One of the requirements under Pathway B of the Board’s Registration standard: Endorsement for scheduled medicines (ESM registration standard) is the successful completion of 15 online case studies approved by the Board.
The Board has approved the following online case studies for the purpose of Pathway B of the ESM registration standard:
An endorsement for scheduled medicines may be subject to a condition. For more information please visit the Endorsement for schedule medicines subject to a condition page.